Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures

NCT: NCT07325578 · RECRUITING

NCT IDNCT07325578
StatusRECRUITING
Start Date2026-04-28
Completion2026-10

Brief Summary

The goal of this investigational device exemption is to evaluate the Epione assistance for introducer placement during percutaneous procedures in musculo-skeletic (MSK) structures of the pelvis and the spine in adults. The main question is the determination of the rate of feasible procedures assisted by the Epione device Participants will undergo their procedure(s) as planned by their physician. If they accept to participate to the study, the differences with standard of care will be: * The use of the Epione device to place the introducer(s), instead of freehand placement if they do not participate * Additional CT or CBCT scans during the procedure.

Frequently Asked Questions

What is U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures?

U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures is a clinical trial registered under NCT07325578. Current status: RECRUITING.

What is the status of NCT07325578?

The current status of NCT07325578 (U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures) is: RECRUITING.

When did U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures start?

U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures started on 2026-04-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.